Skip to main content

Table 2 Detailed antiplatelet treatment in AMI patients

From: Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry

  Overall population (%/Mean ± SD) STEMI (%/Mean ± SD) NSTEMI (%/Mean ± SD)  P value
  N = 40,202 N = 30,179 N = 10,023
Antiplatelet treatment strategy (n, %)
 Aspirin loading 25,011 (62.2%) 19,901 (65.9%) 5110 (51.0%)  < 0.001
 P2Y12 loading 25,557 (63.6%) 19,993 (66.2%) 5564 (55.5%)  < 0.001
 Aspirin maintenance 37,414 (93.1%) 28,087 (93.1%) 9327 (93.1%) 0.967
 P2Y12 maintenance 36,405 (90.6%) 27,249 (90.3%) 9156 (91.3%) 0.002
 DAPT 36,154 (89.9%) 27,134 (89.9%) 9020 (90.0%) 0.811
  1. STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; DAPT, dual antiplatelet treatment